M. K. Lavtcre
FDA investigator
Appears on 1 document from 2004, mostly at sites in Ukraine. Most often cites current good tissue practice requirements (21 CFR 1271.150).
- 1
- Documents on file
- 7.0
- Observations per 483
- 2004
- First seen
- 2004
- Most recent
What they cite most
From 6 observations- 21 CFR 1271.150Current good tissue practice requirements1
- 21 CFR 1271.180Procedures1
- 21 CFR 1271.190Facilities1
- 21 CFR 1271.55What records must accompany an HCT/P after the donor-eligibility determination is complete; and what records must I retain?1
Activity by year
2004: 1
Where
Ukraine 1
Often inspects with
Is M. K. Lavtcre coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2004-06-12 | 483 BioimplantJun 12, 2004 · Kiev, Ukraine | Kiev, Ukraine | 7 |
About this profile
What does M. K. Lavtcre inspect?
M. K. Lavtcre appears on 1 document on file covering 1 site, mostly in Ukraine.
What do they cite most often?
21 CFR 1271.150 (current good tissue practice requirements), followed by 21 CFR 1271.180 and 21 CFR 1271.190.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for M. K. Lavtcre is dated Jun 12, 2004.